Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Iddo Peleg"'
Autor:
Tony Peled, Iddo Peleg, Joanne Kurtzberg, Einat Galamidi, David Snyder, Paul L. Martin, Suhag Parikh, Joel A. Brochstein, Aurelie Schwarzbach, Uri Goshen, Mitchell E. Horwitz
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:S175-S176
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::138f0c1643788629e23acebe9fb8302a
https://doi.org/10.1016/j.bbmt.2016.12.291
https://doi.org/10.1016/j.bbmt.2016.12.291
Autor:
John P. Chute, Efrat Landau, Einat Galamidi Cohen, Tony Peled, Cristina Gasparetto, Barbara Waters-Pick, David Snyder, Mitchell E. Horwitz, Joanne Kurtzberg, Gwynn D. Long, Steven Wease, Ashley Morris, Iddo Peleg, Hadas Shoham, Keith M. Sullivan, Dorit Aschengrau, Patrick J. Stiff, Nelson J. Chao, Dima Yackoubov, Etty Friend, David A. Rizzieri, Amnon Peled, Carolyn McDonald
Publikováno v:
The Journal of clinical investigation. 124(7)
BACKGROUND. Delayed hematopoietic recovery is a major drawback of umbilical cord blood (UCB) transplantation. Transplantation of ex vivo–expanded UCB shortens time to hematopoietic recovery, but long-term, robust engraftment by the expanded unit ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::927c85766c413a3c2c475a72e2e246ff
https://pubmed.ncbi.nlm.nih.gov/24911148
https://pubmed.ncbi.nlm.nih.gov/24911148
Autor:
Einat Galamidi, Tony Peled, David Snyder, Joanne Kurtzberg, Aurelie Schwarzbach, Uri Goshen, Suhag Parikh, Mitchell E. Horwitz, Paul L. Martin, Iddo Peleg, Joel A. Brochstein
Publikováno v:
Blood. 128:3651-3651
Background: Patients with severe sickle cell disease (SCD) experience organ damage, poor quality of life, and are at high risk of premature mortality. To date, allogeneic hematopoietic stem cell transplant remains the only available curative therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8244f8e32be742d3399ff3ec2d045c2
https://doi.org/10.1182/blood.v128.22.3651.3651
https://doi.org/10.1182/blood.v128.22.3651.3651
Autor:
Sophie Adi, N.G. Rosenheimer, Iddo Peleg, Eitan Fibach, Arnon Nagler, Yaron Daniely, Tony Peled, Amnon Peled
Publikováno v:
Blood. 108:725-725
Nicotinamide (NA) is a non-competitive inhibitor of NAD(+)-dependent ADP-ribosyl transferases, of CD38 NADase (a major regulator of cellular NAD levels) and of Sir2 histone-deacetylase. These enzymes are playing a pivotal role in regulation of signal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16137791e1994e73464bc4f6532aef0e
https://doi.org/10.1182/blood.v108.11.725.725
https://doi.org/10.1182/blood.v108.11.725.725